Sponsor or institution
Clinical trials and research at Geneplus-Beijing Co. Ltd.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Geneplus-Beijing Co. Ltd. that are recruiting, in China. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Timing ctDNA Testing to Guide Treatment in Advanced Breast Cancer | — | Beijing | Recruiting | Jul 2, 2026 |
| Using blood tests to help diagnose breast cancer | — | Beijing, Beijing Municipality | Recruiting | Mar 14, 2025 |
| Exploring ctDNA for Immunotherapy in Advanced Colorectal Cancer | — | Beijing, Beijing Municipality and 1 other locations | Recruiting | Oct 24, 2023 |
| Exploring biomarkers for neoadjuvant immunotherapy in lung cancer | — | Shanghai | Recruiting | Jul 28, 2023 |
| Monitoring circulating tumor DNA in early breast cancer patients | — | Chongqing, Chongqing Municipality | Recruiting | Apr 20, 2020 |
All recruiting trials (5)
-
Timing ctDNA Testing to Guide Treatment in Advanced Breast Cancer
This study tests how ctDNA levels and key gene mutations relate to outcomes and treatment responses in adults with advanced breast cancer.
-
Using blood tests to help diagnose breast cancer
This study is testing whether blood tests that look for specific markers can help doctors tell the difference between breast cancer and non-cancerous conditions.
-
Exploring ctDNA for Immunotherapy in Advanced Colorectal Cancer
This study is testing if tracking changes in tumor DNA can help doctors see how well immunotherapy works for people with advanced colorectal cancer.
-
Exploring biomarkers for neoadjuvant immunotherapy in lung cancer
This study is trying to find out if certain biological markers in patients with advanced lung cancer can help predict how well a new immunotherapy treatment will work before surgery.
-
Monitoring circulating tumor DNA in early breast cancer patients
This study is testing if tracking a specific type of DNA in the blood can help doctors understand how well treatments are working for people with early-stage breast cancer.
Quick answers
How many clinical trials run by Geneplus-Beijing Co. Ltd. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.